BGM Group Ltd. (BGM) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
BGM Group Ltd. (BGM) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry, with a market capitalization near $63.6M, listed on NASDAQ, employing roughly 298 people, carrying a beta of 1.81 to the broader market. BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. Led by Chen Xin, public since 2003-01-24.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for BGM as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.